生物制剂时代急性重度溃疡性结肠炎的早期管理:预测激素应答的预后临床指数开发与国际验证
研究比较英国牛津2015至2019年131例成人急性重度结肠炎住院与1992至1993年数据,发现急诊结肠切除率由29%降至15%,并开发了基于CRP≥100 mg/L、白蛋白≤25 g/L和UCEIS评分的四点模型预测激素无应答,在澳大利亚和印度队列验证。
要点
- 2015至2019年牛津队列急诊结肠切除率15%,低于1992至1993年的29%(p=0.033)。
- 预测激素无应答的四点模型:CRP≥100 mg/L计1分,白蛋白≤25 g/L计1分,UCEIS≥4计1分或≥7计2分。
- 验证队列中评分≥3分预测激素失败的准确率为84%(95% CI 0.70至0.98),OR 11.9(95% CI 10.8至13.0)。
核心结论
- 急性重度结肠炎的急诊结肠切除率25年间在全球范围减半至8%至15%,激素无应答患者入院时即可识别并可能优先早期强化治疗。
研究设计与样本
- 比较英国牛津2015至2019年131例成人急性重度结肠炎住院(117例患者)与1992至1993年数据,并在澳大利亚Gold Coast University Hospital(2015至2020年,n=110)和印度All India Institute of Medical Sciences, New Delhi(2018至2020年,n=62)验证预测模型。
主要发现
- 2015至2019年牛津队列15%需急诊结肠切除,1992至1993年为29%(p=0.033)。
- 2015至2019年牛津队列71例(54%)接受医疗救援治疗(27%环孢素,27%抗肿瘤坏死因子),1992至1993年环孢素为27%(p=0.0015)。
- 入院CRP(错误发现率p=0.00066)、白蛋白(p=0.0066)和UCEIS评分(p=0.015)预测激素无应答。
- 验证队列中评分0、1、2、3和4分的激素应答率分别为100%、75.0%、54.9%、18.2%和0%。
- 验证队列结肠切除率为8%至11%。
关键数值与推荐
- 四点模型:CRP≥100 mg/L计1分,白蛋白≤25 g/L计1分,UCEIS评分≥4计1分或≥7计2分。
- 评分≥3分预测激素失败的准确率为84%(95% CI 0.70至0.98),OR 11.9(95% CI 10.8至13.0)。
临床怎么用
- 患者入院时即可识别可能对皮质激素无应答者,并可能优先早期强化治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: We aimed to determine whether changes in acute severe colitis (ASC) management have translated to improved outcomes and to develop a simple model predicting steroid non-response on admission. DESIGN: Outcomes of 131 adult ASC admissions (117 patients) in Oxford, UK between 2015 and 2019 were compared with data from 1992 to 1993. All patients received standard treatment with intravenous corticosteroids and endoscopic disease activity scoring (Ulcerative Colitis Endoscopic Index of Severity (UCEIS)). Steroid non-response was defined as receiving medical rescue therapy or surgery. A predictive model developed in the Oxford cohort was validated in Australia and India (Gold Coast University Hospital 2015-2020, n=110; All India Institute of Medical Sciences, New Delhi 2018-2020, n=62). RESULTS: In the 2015-2019 Oxford cohort, 15% required colectomy during admission vs 29% in 1992-1993 (p=0.033), while 71 (54%) patients received medical rescue therapy (27% ciclosporin, 27% anti-tumour necrosis factor, compared with 27% ciclosporin in 1992-1993 (p=0.0015). Admission C reactive protein (CRP) (false discovery rate, p=0.00066), albumin (0.0066) and UCEIS scores (0.015) predicted steroid non-response. A four-point model was developed involving CRP of ≥100 mg/L (one point), albumin of ≤25 g/L (one point), and UCEIS score of ≥4 (1 point) or ≥7 (2 points). Patients scoring 0, 1, 2, 3 and 4 in the validation cohorts had steroid response rates of 100, 75.0%, 54.9%, 18.2% and 0%, respectively. Scoring of ≥3 was 84% (95% CI 0.70 to 0.98) predictive of steroid failure (OR 11.9, 95% CI 10.8 to 13.0). Colectomy rates in the validation cohorts were were 8%-11%. CONCLUSIONS: Emergency colectomy rates for ASC have halved in 25 years to 8%-15% worldwide. Patients who will not respond to corticosteroids are readily identified on admission and may be prioritised for early intensification of therapy.
引用
- Adams A, Gupta V, Mohsen W, et al. Early management of acute severe UC in the biologics era: development and international validation of a prognostic clinical index to predict steroid response. Gut. 2022. PMID: 36171080. doi:10.1136/gutjnl-2022-327533
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。